Clinical Trial Update: A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating ALN-4324 for improving insulin sensitivity in adults with Type 2 diabetes mellitus. The study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ALN-4324

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Status: RECRUITING